Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study-Reference-Cited by-同舟云学术

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

Published:2017-10-05 Issue:12 Volume:72 Page:3471-3480
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Pullman J¹,Gardovskis J²,Farley B³,Sun E⁴,Quintas M⁴,Lawrence L⁴,Ling R⁵,Cammarata S⁴,

Affiliation:

1. Mercury Street Medical, Butte, MT, USA

2. Pauls Stradins Clinical University Hospital, Riga, Latvia

3. FCPP Clinical Research Facility, Modesto, CA, USA

4. Melinta Therapeutics, Lincolnshire, IL, USA

5. H2O Clinical, Hunt Valley, MD, USA

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/12/3471/24332168/dkx329.pdf

Reference33 articles.

1. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America;Stevens;Clin Infect Dis,2014

2. Practice guidelines for the diagnosis and management of skin and soft-tissue infections;Stevens;Clin Infect Dis,2005

3. Impact of evolving epidemiology on treatments for complicated skin and skin structure infections: the surgical perspective;Barie;J Am Coll Surg,2015

4. How to stratify patients at risk for resistant bugs in skin and soft tissue infections?;Guillamet;Curr Opin Infect Dis,2016

5. New antibiotics for bad bugs: where are we?;Bassetti;Ann Clin Microbiol Antimicrob,2013

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) – 2023 SPILF;Infectious Diseases Now;2024-02

2. Parenteral Vancomycin in the Treatment of MRSA-Associated Diabetic Foot Infections: An Unnecessary Risk;The International Journal of Lower Extremity Wounds;2023-10-27

3. Updated Review on Clinically-Relevant Properties of Delafloxacin;Antibiotics;2023-07-28

4. Staphylococcus Infections and Emerging Drug Resistance: A Global Concern;Journal of Medical Academics;2023-06-28

5. New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA);Antibiotics;2023-04-12